FFA
VRTX icon

Founders Financial Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History

Founders Financial Alliance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Sell
1,011
-53
-5% -$23.5K 0.07% 239
2026
Q1 		$475K Sell
1,064
-37
-3% -$17.3K 0.09% 220
2025
Q4 		$499K Buy
1,101
+56
+5% +$24.1K 0.09% 197
2025
Q3 		$409K Buy
1,045
+226
+28% +$94.5K 0.08% 236
2025
Q2 		$365K Sell
819
-49
-6% -$22.6K 0.08% 225
2025
Q1 		$421K Buy
+868
New +$404K 0.1% 203
2024
Q1 		– Sell
-1,136
Closed -$462K – 575
2023
Q4 		$462K Sell
1,136
-440
-28% -$163K 0.18% 112
2023
Q3 		$548K Sell
1,576
-72
-4% -$25.2K 0.24% 94
2023
Q2 		$580K Buy
1,648
+88
+6% +$29.6K 0.23% 94
2023
Q1 		$507K Sell
1,560
-44
-3% -$13.2K 0.25% 95
2022
Q4 		$463K Sell
1,604
-20
-1% -$6.09K 0.21% 109
2022
Q3 		$470K Buy
+1,624
New +$467K 0.24% 99
2022
Q1 		– Sell
-2,487
Closed -$546K – 482
2021
Q4 		$546K Buy
+2,487
New +$484K 0.22% 105
2021
Q3 		– Sell
-2,361
Closed -$477K – 483
2021
Q2 		$477K Buy
2,361
+94
+4% +$19.7K 0.22% 107
2021
Q1 		$488K Buy
2,267
+340
+18% +$74.7K 0.24% 92
2020
Q4 		$456K Buy
1,927
+1,883
+4,280% +$432K 0.26% 90
2020
Q3 		$12K Buy
+44
New +$12.1K 0.01% 728

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Founders Financial Alliance's VRTX Position: Q2 2026 in Review

Founders Financial Alliance reduced its Vertex Pharmaceuticals (VRTX) stake by 5% in Q2 2026, selling an estimated $23.5K and leaving 1,011 shares worth $502K. The position accounts for 0.07% of the portfolio, ranked #239.

Founders Financial Alliance first reported a position in VRTX in Q3 2020 and has held it in 17 quarters since. The position peaked at $580K in Q2 2023. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Founders Financial Alliance held 1,011 shares of Vertex Pharmaceuticals worth $502K as of Q2 2026.
  • Founders Financial Alliance sold 53 Vertex Pharmaceuticals shares in Q2 2026, an estimated $23.5K.
  • Vertex Pharmaceuticals made up 0.07% of Founders Financial Alliance's portfolio in Q2 2026, its #239 holding.
  • Founders Financial Alliance first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Founders Financial Alliance's Vertex Pharmaceuticals position peaked at $580K in Q2 2023.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.